These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36006172)

  • 41. Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.
    Lee CSM; Powell MC; Chen VM
    Methods Mol Biol; 2023; 2663():441-461. PubMed ID: 37204729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin-release assay-negative heparin-induced thrombocytopenia.
    Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
    Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
    Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.
    Sachs UJ; Cooper N; Czwalinna A; Müller J; Pötzsch B; Tiede A; Althaus K
    Thromb Haemost; 2021 Dec; 121(12):1622-1627. PubMed ID: 34169493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
    Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
    J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia.
    Althaus K; Pelzl L; Hidiatov O; Amiral J; Marini I; Bakchoul T
    Thromb Res; 2019 Aug; 180():55-61. PubMed ID: 31220752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies.
    Vayne C; Palankar R; Billy S; Handtke S; Thiele T; Cordonnier C; Pouplard C; Greinacher A; Gruel Y; Rollin J
    Haematologica; 2022 Oct; 107(10):2445-2453. PubMed ID: 35385923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT).
    Müller L; Dabbiru VAS; Schönborn L; Greinacher A
    Expert Opin Pharmacother; 2024 Feb; 25(3):281-294. PubMed ID: 38465524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT).
    Warkentin TE; Sheppard JI; Smith JW; Li N; Moore JC; Arnold DM; Nazy I
    J Thromb Haemost; 2020 Jun; 18(6):1435-1446. PubMed ID: 32167669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
    Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
    Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia.
    Singh A; Toma F; Uzun G; Wagner TR; Pelzl L; Zlamal J; Freytag V; Weich K; Nowak-Harnau S; Rothbauer U; Althaus K; Bakchoul T
    Blood; 2022 Jun; 139(23):3430-3438. PubMed ID: 35679071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
    Lee CSM; Liang HPH; Connor DE; Dey A; Tohidi-Esfahani I; Campbell H; Whittaker S; Capraro D; Favaloro EJ; Donikian D; Kondo M; Hicks SM; Choi PY; Gardiner EE; Clarke LJ; Tran H; Passam FH; Brighton TA; Chen VM
    Blood Adv; 2022 Jun; 6(11):3494-3506. PubMed ID: 35359002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
    Singh B; Kanack A; Bayas A; George G; Abou-Ismail MY; Kohlhagen M; Christ M; Naumann M; Moser K; Smock K; Grazioli A; Murray D; Padmanabhan A
    medRxiv; 2021 Sep; ():. PubMed ID: 34611669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases.
    Gabarin N; Hack M; Revilla R; Arnold DM; Nazy I
    Expert Rev Hematol; 2024; 17(1-3):39-45. PubMed ID: 38149432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
    J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.